Juno Therapeutics Company
Juno Therapeutics is a clinical-stage company, develops immunotherapies for the treatment of cancer.
Headquarters:
Seattle, Washington, United States
Number Of Exists:
2
Total Funding:
310000000
Founded Date:
2013-01-01
Employee Number:
251-500
Last Funding Type:
Series B
Investors Number:
4
Last Funding Date:
2014-08-05
Funding Status:
M&A
Estimated Revenue:
$100M to $500M
Industry:
CAR-T